LAVSX
Price
$16.27
Change
-$0.07 (-0.43%)
Updated
Aug 14 closing price
Net Assets
2.05B
RMFCX
Price
$60.22
Change
-$0.02 (-0.03%)
Updated
Aug 14 closing price
Net Assets
109.95B
Interact to see
Advertisement

LAVSX vs RMFCX

Header iconLAVSX vs RMFCX Comparison
Open Charts LAVSX vs RMFCXBanner chart's image
Lord Abbett Fundamental Equity R4
Price$16.27
Change-$0.07 (-0.43%)
VolumeN/A
Net Assets2.05B
American Funds American Mutual R3
Price$60.22
Change-$0.02 (-0.03%)
VolumeN/A
Net Assets109.95B
LAVSX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVSX vs. RMFCX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVSX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 110B vs. LAVSX (2.05B). RMFCX pays higher dividends than LAVSX: RMFCX (1.26) vs LAVSX (0.82). LAVSX was incepted earlier than RMFCX: LAVSX (10 years) vs RMFCX (23 years). LAVSX (0.95) and RMFCX (0.91) have similar cost to investors . LAVSX is a more actively managed with annual turnover of: 39.00 vs. RMFCX (31.00). LAVSX has a lower initial minimum investment than RMFCX: LAVSX (0) vs RMFCX (250). LAVSX (9.11) and RMFCX (9.06) have marching annual gain over last year. RMFCX (55.33) and LAVSX (53.34) have equivalent 5 years return.
LAVSXRMFCXLAVSX / RMFCX
Total Expense Ratio0.950.91104%
Annual Report Gross Expense Ratio0.950.91104%
Fund Existence10 years23 years-
Gain YTD9.22510.99784%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B110B2%
Annual Yield % from dividends0.821.2665%
Returns for 1 year9.119.06101%
Returns for 3 years29.4523.36126%
Returns for 5 years53.3455.3396%
Returns for 10 years29.4179.0837%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMNWX85.48N/A
N/A
Principal Capital Appreciation A
ABRWX18.32N/A
N/A
DSS AmericaFirstMonthlyRisk-OnRisk-Off I
PGHAX61.90N/A
N/A
Putnam Global Health Care R6
GHAYX43.52N/A
N/A
VanEck Global Resources Fund Y
TEOIX10.03N/A
N/A
Transamerica Emerging Markets Eq I